Jaguar Health Inc (JAGX)
1.04
+0.05
(+5.31%)
USD |
NASDAQ |
Nov 14, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Jaguar Health Free Cash Flow (Quarterly): -8.186M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -8.186M |
March 31, 2024 | -7.047M |
December 31, 2023 | -7.451M |
September 30, 2023 | -6.79M |
June 30, 2023 | -9.056M |
March 31, 2023 | -9.945M |
December 31, 2022 | -6.784M |
September 30, 2022 | -8.585M |
June 30, 2022 | -11.72M |
March 31, 2022 | -7.695M |
December 31, 2021 | -8.923M |
September 30, 2021 | -9.432M |
June 30, 2021 | -9.913M |
March 31, 2021 | -6.708M |
December 31, 2020 | -4.061M |
September 30, 2020 | -2.919M |
June 30, 2020 | -4.002M |
March 31, 2020 | -4.303M |
December 31, 2019 | -3.14M |
September 30, 2019 | -8.54M |
June 30, 2019 | -5.312M |
Date | Value |
---|---|
March 31, 2019 | -3.465M |
December 31, 2018 | -4.902M |
September 30, 2018 | -2.810M |
June 30, 2018 | -5.397M |
March 31, 2018 | -9.628M |
December 31, 2017 | -5.330M |
September 30, 2017 | -3.029M |
June 30, 2017 | -1.178M |
March 31, 2017 | -0.2887M |
December 31, 2016 | -2.727M |
September 30, 2016 | -3.389M |
June 30, 2016 | -3.788M |
March 31, 2016 | -4.614M |
December 31, 2015 | -3.930M |
September 30, 2015 | -3.379M |
June 30, 2015 | -5.692M |
March 31, 2015 | -1.339M |
December 31, 2014 | -1.74M |
September 30, 2014 | -1.842M |
June 30, 2014 | -1.219M |
March 31, 2014 | -0.6131M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.72M
Minimum
Jun 2022
-2.919M
Maximum
Sep 2020
-7.192M
Average
-7.451M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
Perspective Therapeutics Inc | -9.917M |
Alaunos Therapeutics Inc | -1.681M |
Oragenics Inc | -1.544M |
Cocrystal Pharma Inc | -3.699M |
Chimerix Inc | -20.53M |